Akiko Maeda, MD, PhD
Akiko Maeda, MD, PhD, RPB Sybil B. Harrington Catalyst Awardee, Case Western Reserve University School of Medicine, will create induced pluripotent stem cell (iPSC)-derived retinal 3D-optic cups from AMD patients, then test their validity as platforms for individualized drug screening for AMD patients. If successful, these models will greatly accelerate drug screening and development for the treatment of AMD.
June 15, 2015
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Research Scientists & Grantees | Eye Care Specialists | Donors & Partners |
Research to Prevent Blindness
645 Madison Avenue, Floor 21
New York, NY 10022-1010
Copyright © 2024 Research to Prevent Blindness. All Rights Reserved.
